These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4795545)

  • 1. Letter: Plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura.
    Cameron JS; Vick R
    Lancet; 1973 Oct; 2(7835):975. PubMed ID: 4795545
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in three siblings.
    Elias M; Horowitz J; Tal I; Kohn D; Flatau E
    Arch Dis Child; 1988 Jun; 63(6):644-6. PubMed ID: 3389894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.
    Richards A; Goodship JA; Goodship TH
    Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):431-5. PubMed ID: 12105394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome.
    Leung DY; Moake JL; Havens PL; Kim M; Pober JS
    Lancet; 1988 Jul; 2(8604):183-6. PubMed ID: 2899661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?
    Johnson S; Waters A
    Immunobiology; 2012 Feb; 217(2):235-43. PubMed ID: 21852019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Haemolytic uremic syndrome and thrombotic thrombocytopenic purpura: classification based on molecular etiology and review of recent developments in diagnostics].
    Prohászka Z
    Orv Hetil; 2008 Jul; 149(27):1251-61. PubMed ID: 18579464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Serum-complement levels in haemolytic-uraemic syndrome.
    Kaplan BS; Thomson PD; MacNab GM
    Lancet; 1973 Dec; 2(7844):1505-6. PubMed ID: 4129358
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement activation in thrombotic microangiopathy.
    Karpman D; Tati R
    Hamostaseologie; 2013 May; 33(2):96-104. PubMed ID: 23411690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Serum-complement levels in haemolytic-uraemic syndrome.
    Monnens L; Hendrickx G; van Wieringen P; van Munster P
    Lancet; 1974 Aug; 2(7875):294. PubMed ID: 4135724
    [No Abstract]   [Full Text] [Related]  

  • 10. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the microangiopathic haemolytic anaemia's.
    Chandy M; Bhushan V
    J Assoc Physicians India; 1994 Jun; 42(6):470, 475-7. PubMed ID: 7852233
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
    Stühlinger W; Kourilsky O; Kanfer A; Sraer JD
    Lancet; 1974 Sep; 2(7883):788-9. PubMed ID: 4143056
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative immunopathologic studies of thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome and disseminated intravascular coagulation.
    Hayasaka T; Yoshiki T; Shirai T; Ninomura N; Itoh T
    Acta Pathol Jpn; 1981 Jul; 31(4):569-81. PubMed ID: 7197110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcaemia associated with plasma infusion therapy for thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Report of two cases.
    Van der Meer J; De Vries EG; Van der Geest S; De Jong PE
    Neth J Med; 1985; 28(9):361-5. PubMed ID: 4047270
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemolytic uraemic syndrome and thrombocytopenic thrombotic purpura.
    Zijlstra JG; Das PC
    Int J Artif Organs; 1997 Apr; 20(4):191-4. PubMed ID: 9195234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
    Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
    Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultralarge von Willebrand factor-induced platelet clumping and activation of the alternative complement pathway in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromes.
    Turner N; Sartain S; Moake J
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):509-24. PubMed ID: 26043389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
    Dragon-Durey MA; Frémeaux-Bacchi V
    Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in HIV-infected patients.
    Bachmeyer C; Blanche P; Séréni D; Salmon D; Grateau G; Dreyfus F; Sicard D
    AIDS; 1995 May; 9(5):532-3. PubMed ID: 7639985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.